WGS

GeneDx Holdings Corp. (WGS), headquartered in Stamford, Connecticut, is a prominent player in the genomic diagnostics sector, focusing on precision medicine through advanced genetic testing solutions. The company aims to transform the landscape of healthcare by improving the understanding and management of genetic disorders, thereby empowering healthcare providers and patients alike with valuable insights for optimal health outcomes. With a diverse range of diagnostic services and a strong commitment to leveraging cutting-edge technology, GeneDx is strategically positioned to significantly influence the future of genomics and personalized medicine on a global stage.